{
    "clinical_study": {
        "@rank": "130937", 
        "arm_group": [
            {
                "arm_group_label": "CSP/SMFP Dentifrice", 
                "arm_group_type": "Experimental", 
                "description": "Dentifrice containing high fluoride content as SMFP and CSP"
            }, 
            {
                "arm_group_label": "SMFP Dentifrice Prototype 1", 
                "arm_group_type": "Active Comparator", 
                "description": "Dentifrice containing high fluoride content as SMFP and no CSP"
            }, 
            {
                "arm_group_label": "SMFP Dentifrice Prototype 2", 
                "arm_group_type": "Active Comparator", 
                "description": "Dentifrice containing low fluoride content as SMFP and no CSP"
            }, 
            {
                "arm_group_label": "CSP Dentifrice", 
                "arm_group_type": "Active Comparator", 
                "description": "Dentifrice containing CSP but no fluoride"
            }, 
            {
                "arm_group_label": "Placebo Dentifrice", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Dentifrice containing no CSP and no fluoride"
            }
        ], 
        "brief_summary": {
            "textblock": "In situ study to compare treatment effect on enamel remineralization potential, measured by\n      surface microhardness recovery (SMHR) and Enamel Fluoride Uptake (EFU). The study will\n      explore the efficacy of an experimental sodium monofluorophosphate (SMFP) dentifrice\n      containing calcium sodium phosphosilicate (CSP) in comparison to an experimental SMFP only\n      dentifrice."
        }, 
        "brief_title": "Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Caries", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Wears a removable bilateral mandibular partial denture that has good stability and\n             support, with sufficient room on each side in the posterior buccal flange area to\n             accommodate two enamel specimens [required dimensions 12 x 7 millimeters (mm)]."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01657877", 
            "org_study_id": "RH01381"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "CSP/SMFP Dentifrice", 
                    "CSP Dentifrice"
                ], 
                "description": "CSP high percentage weight by weight", 
                "intervention_name": "Calcium sodium phosphosilicate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "SMFP Dentifrice Prototype 2", 
                    "CSP/SMFP Dentifrice", 
                    "SMFP Dentifrice Prototype 1"
                ], 
                "description": "500 to 1500 parts per million (ppm) of fluoride", 
                "intervention_name": "Sodium monoflurophosphate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo Dentifrice", 
                "description": "No CSP and no fluoride", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Fluorophosphate"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 15, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Indianapolis", 
                    "country": "United States", 
                    "state": "Indiana", 
                    "zip": "46202"
                }, 
                "name": "Indiana University School of Dentistry"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "5", 
        "official_title": "In Situ Study to Confirm the Anti-caries Potential of a 1.1365% w/w Sodium Monofluorophosphate (1500ppm F) Dentifrice", 
        "overall_official": {
            "affiliation": "GlaxoSmithKline", 
            "last_name": "GSK Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "SMHR test was used to assess the changes in mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMHR was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Percent SMHR was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first demineralization challenge (D1) using formula: [(D1-R)/ (D1-B)]*100.", 
            "measure": "Percentage surface microhardness recovery (SMHR) of test dentifrice containing 1500 ppm fluoride as SMFP and 5 % w/w CSP relative to reference dentifrice containing 1500 ppm fluoride as SMFP and 0 % w/w CSP", 
            "safety_issue": "No", 
            "time_frame": "Baseline to 21 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01657877"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "SMHR test was used to assess the changes in mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMHR was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Percent SMHR was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first demineralization challenge (D1) using formula: [(D1-R)/ (D1-B)]*100.", 
                "measure": "Percentage SMHR of reference dentifrices containing 500 ppm fluoride as SMFP and 0 % w/w CSP, no fluoride as SMFP and no CSP, and no fluoride as SMFP and 5 % w/w CSP.", 
                "safety_issue": "No", 
                "time_frame": "Baseline to 21 days"
            }, 
            {
                "description": "EFU was determined using the microdrill enamel biopsy technique. The amount of fluoride uptake by enamel was calculated based on the amount of fluoride divided by the area of the enamel cores. The difference between treatments was calculated with respect to fluoride uptake by enamel.", 
                "measure": "Percentage enamel fluoride uptake (EFU)", 
                "safety_issue": "No", 
                "time_frame": "Baseline to 21 days"
            }
        ], 
        "source": "GlaxoSmithKline", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}